XML 66 R68.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Stock Appreciation Rights Activity (Detail) (Stock Appreciation Rights [Member], USD $)
In Thousands, except Share data, unless otherwise specified
1 Months Ended 12 Months Ended
Nov. 30, 2012
Aug. 31, 2012
Dec. 31, 2014
Dec. 31, 2012
Dec. 31, 2013
Stock Appreciation Rights [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares, Grants outstanding at beginning of the period     170,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
   
Shares, Granted 100,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
70,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
  170,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Shares, Grants outstanding at end of the period     170,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
170,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Shares, Grants exercisable at end of the period     92,916srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisable
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
  50,416srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisable
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Shares, Grants vested and expected to vest at end of the period     170,000srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
170,000srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
170,000srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted Average Exercise Price per Share, Grants outstanding at beginning of the period     $ 18.18srpt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
   
Weighted Average Exercise Price per Share, Granted       $ 18.18srpt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Weighted Average Exercise Price per Share, Grants outstanding at end of the period     $ 18.18srpt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
$ 18.18srpt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Weighted Average Exercise Price per Share, Grants exercisable at end of the period     $ 17.80srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsExercisableInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
  $ 17.48srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsExercisableInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted Average Exercise Price per Share, Grants vested and expected to vest at end of the period     $ 18.18srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
$ 18.18srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
$ 18.18srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Stock Appreciation Rights, Aggregate Intrinsic Value          
SARs outstanding at December 31, 2014     $ 307us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
   
SARs exercisable at December 31, 2014     179srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableIntrinsicValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
   
SARs vested and expected to vest at December 31, 2014     $ 307srpt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestAggregateIntrinsicValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
   
Stock Appreciation Rights, Weighted Average Remaining Contractual Life          
SARs outstanding at December 31, 2014     7 years 9 months 4 days    
SARs exercisable at December 31, 2014     7 years 9 months 4 days    
SARs vested and expected to vest at December 31, 2014     7 years 9 months 4 days